World Cognitive Function & Memory Enhancement Market Research Report (to 2027)
Global Cognitive Function & Memory Enhancement Market (up to 2027): By Product, By Application, By Region
360iResearch predicts that the global cognitive function and memory enhancement market, which was valued at $8,426.43 million in 2021, will reach $9,308.67 million in 2022 and expand to $15,528.04 million by 2027, growing at a CAGR of 10.72%. This research report analyzes the global market for cognitive function and memory enhancement from multiple perspectives, including an introduction, research methodology, executive summary, market overview, market insights, product analysis (Adderall, Aricept, Exelon, Namenda, Provigil), application analysis (disease treatment, education, sports), regional analysis (North and South America, the United States, Canada, Brazil, Asia-Pacific, Japan, China, India, South Korea, Taiwan, Europe/Middle East/Africa, the United Kingdom, Germany, France, Russia, and others), competitive landscape, and company information.
- Company：マーケットリサーチセンター
- Price：Other
